首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1593484

血液培養測試市場規模、佔有率和成長分析（按技術、應用、最終用途和地區）：產業預測（2024-2031）

Blood Culture Tests Market Size, Share, Growth Analysis, By Technique (Conventional, Automated), By Application (Bacterial Infections, Fungal Infections), By End Use (Hospital Laboratories, Reference Laboratories), By Region -Industry Forecast 2024-2031

出版日期: 2024年11月08日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球血液培養檢測市場規模估值為61.6億美元，從2023年的69.2億美元成長到2031年的175億美元，在預測期間（2024-2031）預計年複合成長率為12.3% 。

由於血流感染疾病(BSI) 創新診斷產品的核准不斷增加以及 BSI 盛行率不斷上升，全球血液培養檢測市場正經歷顯著成長。血液培養測試對於識別血液中的有害微生物（例如細菌和真菌）非常重要。此診斷程序包括提取血液樣本並在無菌環境中培養，以促進這些病原體的生長，從而識別可能導致敗血症等嚴重的感染疾病。及時、準確的檢測結果對於指南醫療保健專業人員制定有針對性的抗生素治療、改善患者照護、減少感染疾病傳播和改善康復結果至關重要。此類檢測的需求量很大，因為它們在有效的感染控制中發揮著至關重要的作用。

市場概況
消耗品
血培養基
有氧血培養基
兒科需氧血培養基
厭氧血培養基
結核分枝桿菌血培養基
真菌/酵母血培養基
檢測試劑套件/試劑
血液培養配件
裝置
全自動血液培養系統
實驗室設備支援
培養箱
菌落計數器
顯微鏡
革蘭氏染色設備
軟體服務

全球血液培養檢測市場規模（按技術）/年複合成長率（2024-2031）

市場概況
基於文化的技術
分子技術
微陣列
PCR（聚合酵素鏈鎖反應）
PNA-FiSH（勝胜肽核酸-螢光雜合反應）
蛋白質體學技術

全球血液培養檢測市場規模（按應用）/年複合成長率（2024-2031）

市場概況
菌血症
真菌血症
結核分枝桿菌檢測

全球血液培養檢測市場規模（依最終用戶）/年複合成長率（2024-2031）

市場概況
醫院實驗室
參考實驗室
學術實驗室
其他考場

全球血液培養檢測市場規模/年複合成長率（2024-2031）

北美（依方法、產品、技術、應用、最終用戶）
- 美國
- 加拿大
歐洲（依方法、產品、技術、應用程式、最終用戶）
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲國家
亞太地區（依方法、產品、技術、應用、最終用戶）
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲（依方法、產品、技術、應用、最終用戶）
- 巴西
- 其他拉丁美洲
中東/非洲（依方法、產品、技術、應用、最終用戶）
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

雅培（美國）
F. Hoffmann-La Roche Ltd（瑞士）
諾華公司（瑞士）
禮來公司（美國）
默克公司（美國）
賽默飛世爾科技公司（美國）
西門子（德國）
丹納赫公司（美國）
ZEPTOMETRIX（美國）
CytoTest Inc.（美國）
德維瑟（瑞典）
布魯克（美國）
生物梅里埃（法國）
拜耳公司（德國）
BD（美國）

結論和建議

簡介目錄

Product Code: SQMIG35D2281

Global Blood Culture Tests Market size was valued at USD 6.16 billion in 2022 and is poised to grow from USD 6.92 billion in 2023 to USD 17.50 billion by 2031, growing at a CAGR of 12.3% during the forecast period (2024-2031).

The global blood culture tests market is experiencing significant growth driven by the increasing approval of innovative diagnostic products for bloodstream infections (BSIs) and the rising prevalence of BSIs. Blood culture tests are critical in identifying harmful microorganisms such as bacteria or fungi in the bloodstream. This diagnostic procedure involves extracting a blood sample and cultivating it in a sterile environment to promote the growth of these pathogens, enabling the identification of infections that may lead to severe conditions like sepsis. Timely and accurate results are essential for guiding medical professionals in prescribing targeted antimicrobial treatments, improving patient care, reducing the spread of infections, and enhancing recovery outcomes. The demand for such tests is rising due to their crucial role in effective infection management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Culture Tests market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Culture Tests Market Segmental Analysis

Global Blood Culture Tests Market is segmented based on the Method, Product, Technology, Application, End-Use, and Region. Based on Product, the market is segmented into Conventional/Manual Methods, Automated Methods. Based on Product, the market is segmented into Consumables, Instruments, Software and Services. Based on Technology, the market is segmented into Culture-based Technology, Molecular Technology, Proteomics Technology. Based on Application, the market is segmented into Bacteremia, Fungemia, Mycobacterial Detection. Based on End Use, the market is segmented into Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, Other Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Blood Culture Tests Market

The rising global prevalence of bloodstream infections has significantly driven the demand for accurate and swift diagnostic solutions like blood culture tests. A 2023 World Health Organization report highlighted a notable rise in sepsis cases worldwide, underscoring the critical role of timely diagnosis in implementing effective treatment strategies. This growing urgency has led to increased investments in cutting-edge blood culture technologies, fueling advancements in the diagnostic solutions market aimed at combating infectious diseases. As a result, the blood culture tests market is experiencing accelerated growth, driven by the need for enhanced diagnostic accuracy and speed in addressing these life-threatening infections.

Restraints in the Global Blood Culture Tests Market

A significant restraint in the global blood culture tests market is the difficulty in interpreting blood culture results. Distinguishing between contaminants and clinically relevant pathogens requires specialized expertise, which can limit market growth by increasing reliance on skilled professionals and raising concerns about the accuracy of results. While improving training for medical personnel and enhancing reporting systems can help address these challenges, they do not fully resolve the complexities involved in interpreting the outcomes. This ongoing issue could hinder the widespread adoption and effectiveness of blood culture tests, as healthcare providers remain cautious about their reliability in diagnosing infections.

Market Trends of the Global Blood Culture Tests Market

One key trend in the global blood culture tests market is the growing emphasis on medical education and training programs. These initiatives are playing a pivotal role in raising awareness among healthcare professionals about the significant benefits of blood culture tests, particularly in the early and accurate diagnosis of sepsis. Workshops and seminars dedicated to sepsis management are becoming increasingly common, helping to underline the importance of timely blood culture testing. As awareness increases, it leads to improved patient care and creates crucial growth opportunities for the market. This heightened focus on education is driving the adoption of blood culture tests, further expanding their role in clinical settings.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Pricing Analysis

Global Blood Culture Tests Market Size by Method & CAGR (2024-2031)

Market Overview
Conventional/Manual Methods
Automated Methods

Global Blood Culture Tests Market Size by Product & CAGR (2024-2031)

Market Overview
Consumables
Blood Culture Media
Aerobic Blood Culture Media
Pediatric Aerobic Blood Culture Media
Anaerobic Blood Culture Media
Mycobacterial Blood Culture Media
Fungi/Yeast Blood Culture Media
Assay Kits & Reagents
Blood Culture Accessories
Instruments
Automated Blood Culture Systems
Supporting Laboratory Equipment
Incubators
Colony Counters
Microscopes
Gram Stainers
Software and Service

Global Blood Culture Tests Market Size by Technology & CAGR (2024-2031)

Market Overview
Culture-Based Technology
Molecular Technologies
Microarrays
PCR (Polymerase Chain Reaction)
PNA-FiSH (Peptide Nucleic Acid - Fluroscent in Situ Hybridization)
Proteomics Technology

Global Blood Culture Tests Market Size by Application & CAGR (2024-2031)

Market Overview
Bacteremia
Fungemia
Mycobacterial Detection

Global Blood Culture Tests Market Size by End User & CAGR (2024-2031)

Market Overview
Hospital Laboratories
Reference Laboratories
Academic Research Laboratories
Other Laboratories

Global Blood Culture Tests Market Size & CAGR (2024-2031)

North America, (Method, Product, Technology, Application, End User)
- US
- Canada
Europe, (Method, Product, Technology, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Method, Product, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Method, Product, Technology, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Method, Product, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Abbott (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZEPTOMETRIX (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CytoTest Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Devyser (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOMERIEUX (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments